Optical Spectroscopy for Skin Carcinomas' Surgical Management
NCT ID: NCT02956265
Last Updated: 2022-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
142 participants
INTERVENTIONAL
2016-10-31
2021-03-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A non-invasive, non-traumatic, automated and real-time help for the clinical diagnosis orientation of such skin lesions could help improving diagnosis accuracy of the medical practitioner's visual inspection:
* In terms of sensitivity in order to potentially decrease the number of actinic keratosis evolving towards invasive carcinoma,
* In terms of specificity in order to potentially decrease useless resections and reduce resection margins and therefore reduce scars surface.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors
NCT05842421
One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy
NCT02285790
A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions
NCT00633516
Reflectance Confocal Microscopy in Basal Cell Carcinoma
NCT02623101
Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas
NCT02125669
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients - Suffering from carcinomatous or polymorphous skin
bimodal optical spectroscopy
an optical fiber will be put in gentle contact with the patient's skin in order to acquire optical spectra
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bimodal optical spectroscopy
an optical fiber will be put in gentle contact with the patient's skin in order to acquire optical spectra
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Autonomous: enjoying full citizenship rights and full mental abilities, and
* Affiliated to a social security system, and
* Suffering from carcinomatous or polymorphous skin lesions that can be fully managed in an outpatient (ambulatory) surgery procedure.
Exclusion Criteria
* Carcinomatous or polymorphous skin lesions for which resection margins are uncertain, or
* Naevomatous skin lesions and related skin pathologies.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lorraine
OTHER
Centre Hospitalier Régional Metz-Thionville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHR Metz Thionville
Metz, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-05-CHRMT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.